Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01034631
Show Display Options
Rank Status Study
1 Active, not recruiting BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Interventions: Drug: Everolimus;   Drug: BNC105P

Study has passed its completion date and status has not been verified in more than two years.